Evidence map›Paper›PMID 29979493›Full record

ArticleChembiochem : a European journal of chemical biology2018

Azide- and Alkyne-Bearing Metabolic Chemical Reporters of Glycosylation Show Structure-Dependent Feedback Inhibition of the Hexosamine Biosynthetic Pathway.

Lisa A Walter, Anna R Batt, Narek Darabedian, Balyn W Zaro, Matthew R Pratt

Open access · greenAbstract read
In one paragraph

Article in Chembiochem : a European journal of chemical biology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.5field-weighted citation impact, top 37% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 9 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Chemical reporters to study mammalian O-glycosylation.Biochemical Society transactions · 2021
    Review
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Lisa A WalterDepartment of Chemistry, University of Southern California, 840 Downey Way, LJS 250, Los Angeles, CA, 90089, USA.
Anna R BattDepartment of Chemistry, University of Southern California, 840 Downey Way, LJS 250, Los Angeles, CA, 90089, USA.
Narek DarabedianDepartment of Chemistry, University of Southern California, 840 Downey Way, LJS 250, Los Angeles, CA, 90089, USA.
Balyn W ZaroDepartment of Chemistry, University of Southern California, 840 Downey Way, LJS 250, Los Angeles, CA, 90089, USA.
Matthew R PrattDepartment of Chemistry, University of Southern California, 840 Downey Way, LJS 250, Los Angeles, CA, 90089, USA.ORCID 0000-0003-3205-5615
University of Southern California · US

Funding

Chemical Tools for the Investigation and Manipulation of Protein GlycosylationR01GM125939 · NIGMS · UNIVERSITY OF SOUTHERN CALIFORNIA · PI PRATT, MATTHEW ROBERT · 2017 to 2025
$2.4M
NIGMS NIH HHS R01 GM125939
6 · The paper itself

Abstract

Metabolic chemical reporters (MCRs) of protein glycosylation are analogues of natural monosaccharides that bear reactive groups, like azides and alkynes. When they are added to living cells and organisms, these small molecules are biosynthetically transformed into nucleotide donor sugars and then used by glycosyltransferases to modify proteins. Subsequent installation of tags by bioorthogonal chemistries can then enable the visualization and enrichment of these glycoproteins. Although this two-step procedure is powerful, the use of MCRs has the potential to change the endogenous production of the natural repertoire of donor sugars. A major route for the generation of these glycosyltransferase substrates is the hexosamine biosynthetic pathway (HBP), which results in uridine diphosphate N-acetylglucosamine (UDP-GlcNAc). Interestingly, the rate-determining enzyme of the HBP, glutamine fructose-6-phosphate amidotransferase (GFAT), is feedback inhibited by UDP-GlcNAc. This raises the possibility that a build-up of UDP-MCRs would block the biosynthesis of UDP-GlcNAc, resulting in off target effects. Here, we directly test this possibility with recombinant human GFAT and a small panel of synthetic UDP-MCRs. We find that MCRs with larger substitutions at the N-acetyl position do not inhibit GFAT, whereas those with modifications of the 2- or 6-hydroxy group do. These results further illuminate the considerations that should be applied to the use of MCRs.

Indexed as

Biosynthetic PathwaysAlkynesAzidesClick ChemistryGlutamine-Fructose-6-Phosphate Transaminase (Isomerizing)GlycosylationHexosaminesHumansRecombinant ProteinsUridine DiphosphateAlkynesAzidesGlutamine-Fructose-6-Phosphate Transaminase (Isomerizing)HexosaminesRecombinant ProteinsUridine Diphosphateamidotransferasesclick chemistryglycosylationhexosaminemetabolic chemical reporters

Identifiers

PMID29979493
PMCPMC6261355
OpenAlexW2845286252

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.